MGX
Metagenomi Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.46
-0.11 ▼ -7.01%
🌙 3월 13일 4:27 PM ET (한국 3/14 05:27)
$1.47
+0.01 ▲ +0.68%
| Index | - | P/E | - | EPS (ttm) | -2.36 | Insider Own | 29.94% | Shs Outstand | 0.04B | Perf Week | -1.35% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 4.27% | Insider Trans | -0.15% | Shs Float | 0.03B | Perf Month | -3.95% |
| Enterprise Value | -0.07B | PEG | - | EPS next Q | -0.53 | Inst Own | 18.29% | Short Float | 7.33% | Perf Quarter | -19.78% |
| Income | -0.09B | P/S | 2.18 | EPS this Y | 11.47% | Inst Trans | 4.6% | Short Ratio | 6.75 | Perf Half Y | -22.75% |
| Sales | 0.03B | P/B | 0.35 | EPS next 5Y | 6.93% | ROA | -31.5% | Short Interest | 1.93M | Perf YTD | -9.88% |
| Book/sh | 4.22 | P/C | 0.34 | EPS past 3/5Y | -26.57% -42.49% | ROE | -44.67% | 52W High | -63.04% ($3.95) | Perf Year | -23.56% |
| Cash/sh | 4.27 | P/FCF | - | Sales past 3/5Y | 13.59% 219.15% | ROIC | -45.47% | 52W Low | 18.7% ($1.23) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 9.77% | Gross Margin | 78.91% | Volatility(W/M) | 10.42% 7.5% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | -2.59 | Sales Y/Y TTM | -51.79% | Oper. Margin | -380.85% | ATR (14) | 0.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.22 | EPS Q/Q | 4.24% | Profit Margin | -348.54% | RSI (14) | 44.38 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.22 | Sales Q/Q | -59.32% | SMA20 | -4.92% ($1.54) | Beta | 0.28 | Target Price | $9.5 |
| Payout | - | Debt/Eq | 0.26 | Earnings | 3000000 | SMA50 | -8.28% ($1.59) | Rel Volume | 1.18 | Prev Close | $1.57 |
| Employees | 119 | LT Debt/Eq | 0.22 | EPS/Sales Surpr. | 2.62% -46.64% | SMA200 | -23.68% ($1.91) | Avg Volume(3M) | 0.29M | Price | $1.46 |
| IPO | 2024/2/9 | Option/Short | No/Yes | Trades | 1121 | Volume | 336,673 | Change | -7.01% |
뉴스 로딩 중...